PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $391,462 | +31.3% | 14,204 | +6.7% | 0.01% | +18.2% |
| Q3 2023 | $298,232 | -43.5% | 13,308 | +2.4% | 0.01% | -42.1% |
| Q2 2023 | $528,303 | -11.3% | 12,990 | +5.7% | 0.02% | -17.4% |
| Q1 2023 | $595,569 | +183717.6% | 12,295 | +44.8% | 0.02% | +76.9% |
| Q4 2022 | $324 | -99.9% | 8,489 | -0.1% | 0.01% | -31.6% |
| Q3 2022 | $427,000 | +31.8% | 8,498 | +5.2% | 0.02% | +35.7% |
| Q2 2022 | $324,000 | +6.9% | 8,076 | -0.6% | 0.01% | +27.3% |
| Q1 2022 | $303,000 | -9.3% | 8,125 | -3.0% | 0.01% | 0.0% |
| Q4 2021 | $334,000 | +18.0% | 8,377 | +38.1% | 0.01% | -15.4% |
| Q3 2020 | $283,000 | -11.6% | 6,064 | -3.9% | 0.01% | -18.8% |
| Q2 2020 | $320,000 | +53.8% | 6,307 | +57.1% | 0.02% | -15.8% |
| Q4 2014 | $208,000 | – | 4,015 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |